Global Information
회사소개 | 문의 | 비교리스트

조영제(영상진단) : 세계 시장 분석 및 예측 모델(COVID-19가 시장에 미치는 영향)

Contrast Agents (Diagnostic Imaging) - Global Market Analysis and Forecast Model (COVID-19 Market Impact)

리서치사 GlobalData
발행일 2020년 12월 상품 코드 979401
페이지 정보 영문
US $ 7,500 ₩ 9,117,000 Excel (Single User License)
US $ 15,000 ₩ 18,234,000 Excel (Site License)
US $ 22,500 ₩ 27,350,000 Excel (Global License)

조영제(영상진단) : 세계 시장 분석 및 예측 모델(COVID-19가 시장에 미치는 영향) Contrast Agents (Diagnostic Imaging) - Global Market Analysis and Forecast Model (COVID-19 Market Impact)
발행일 : 2020년 12월 페이지 정보 : 영문

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

2020년 이후 조영제 시장에 대한 COVID-19의 영향을 상세하게 설명했습니다. 조영제는 다양한 병상이나 병리를 보다 명확하게 시각화하기 위해서 방사선과에서 사용됩니다. 조영제는 그 외 모달리티 중에서도 CT, MRI, 초음파에서 사용됩니다. CT 내에서는 대부분의 CT 시술에서 이온성 요오드화제보다 비이온성 요오드화제가 선호됩니다. 바륨 기반 약제는 일반적으로 소화관 영상화에 사용됩니다. MRI 조영제는 다양한 시술에 사용할 수 있는데, 초음파 조영제는 현재 주로 심에코 검사에 사용되고 있습니다.

조영제(Contrast Agents) 시장에 대해 조사했으며, 시장 개요, 2015-2030년간 시장 전망, 부문별/국가별 동향 등의 정보를 전해드립니다.

  • 주요 업계 동향 인사이트
  • 2015-2030년간 부문별 시장 전망
  • 시술 건수, 대수, 평균 판매 가격, 부문별 시장 규모에 관한 상세 데이터

세계 지역/국가별 동향

  • 국가별 분석
  • SWOT 분석
  • 경쟁 동향

의료제도 개요

  • 국가별 의료제도 개요
  • 국가별 상환 방침
  • 국가 고유의 의료 기술 규제 동향

조사 대상 기업 : BayerAG, GE Healthcare LLC, Guerbet SA, Bracco Imaging SpA, Lantheus Medical Imaging, 기타

조사 대상 국가 : 미국, 영국, 독일, 프랑스, 이탈리아, 스페인, 브라질, 중국, 인도, 러시아, 일본, 호주, 캐나다, 멕시코, 한국, 덴마크, 아일랜드, 네덜란드, 뉴질랜드, 남아프리카공화국, 스웨덴, 스위스, 오스트리아, 벨기에, 핀란드, 이스라엘, 노르웨이, 폴란드, 포르투갈, 대만, 체코, 그리스, 헝가리, 터키, 이집트, 사우디아라비아, 아랍에미리트(UAE), 아르헨티나, 칠레

LSH 21.01.08

Contrast Agents (Diagnostic Imaging) - Global Market Analysis and Forecast Model (COVID-19 market impact) is built to visualize quantitative market trends within Diagnostic Imaging therapeutic area.

The model discusses in detail the impact of COVID-19 on Contrast Agents market for the year 2020 and beyond. Contrast agents are used in radiology to get clearer visualizations of various medical conditions and pathologies. These agents are used with computated tomography (CT), magnetic resonance imaging (MRI), and ultrasounds, among other modalities. Within CT, non-ionic iodinated agents are preferred over ionic iodinated agents for most CT procedures. Barium-based agents are generally used for imaging the GI tract. MRI contrast agents can be used for a variety of procedures, while ultrasound contrast agents are currently mainly used for echocardiograms.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Contrast Agents and evolving competitive landscape -

  • Insightful review of the key industry trends.
  • Annualized total Contrast Agents market revenue by segment and market outlooks from 2015-2030.
  • Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -

  • Qualitative market specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country specific insights on the market.
  • SWOT analysis for Contrast Agents market.
  • Competitive dynamics insights and trends provided for Contrast Agents market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

  • Country specific overview of the healthcare system.
  • Country specific reimbursement policies.
  • Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered - Bayer AG, GE Healthcare LLC, Guerbet SA, Bracco Imaging SpA, Lantheus Medical Imaging, and Others

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.


This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

  • CMO executives who must have deep understanding of the Contrast Agents marketplace to make strategic planning and investment decisions.
  • Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
  • Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The Model will enable you to -

  • Understand the impact of COVID-19 on Contrast Agents market.
  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
  • Develop business strategies by understanding the trends shaping and driving Contrast Agents market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Contrast Agents market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
  • Track device sales in the global and country-specific Contrast Agents market from 2015-2030.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
Back to Top
전화 문의